MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SLXN made $3,262K in revenue. -$3,262K in net income. Net profit margin of -100.00%.

Income Overview

Revenue
$3,262K
Net Income
-$3,262K
Net Profit Margin
-100.00%
EPS
$2.88
Unit: Thousand (K) dollars
Revenue Breakdown
    • Total
    • Total
    • Financial expenses

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
Total
2,157 1,018
Total
1,135 1,266
Total operating expenses
3,292 2,284
Operating loss
-3,292 -2,284
Financial expenses
-30 216
Loss before income tax
-3,262 -2,500
Income taxes
0 3
Net loss
-3,262 -2,503
Net loss per share attributable to ordinary shareholders, basic (in dollars per share)
2.88 4.32
Net loss per share attributable to ordinary shareholders, diluted (in dollars per share)
2.88 4.32
Weighted average number of ordinary shares outstanding used in computation of diluted loss per share
1,132,658 579,523
Weighted average number of shares outstanding, basic
1,132,658 579,523
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$3,262K Loss before incometax-$3,262K Financial expenses-$30K Operating loss-$3,292K Total operatingexpenses$3,292K Total$1,135K Total$2,157K

Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Corp (SLXN)